392 related articles for article (PubMed ID: 30569412)
1. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.
Singh V; Falk R; Di Carli MF; Kijewski M; Rapezzi C; Dorbala S
J Nucl Cardiol; 2019 Feb; 26(1):158-173. PubMed ID: 30569412
[TBL] [Abstract][Full Text] [Related]
2. Cardiac scintigraphy with
de Haro-Del Moral FJ; Pubul-Núñez V; Casáns-Tormo I; Jiménez-Heffernan A; Ruano-Pérez R
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):254-266. PubMed ID: 32513587
[TBL] [Abstract][Full Text] [Related]
3. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
Bravo PE; Dorbala S
Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive detection and differentiation of cardiac amyloidosis using
Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
[TBL] [Abstract][Full Text] [Related]
5. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
[TBL] [Abstract][Full Text] [Related]
6.
Khor YM; Cuddy SAM; Singh V; Falk RH; Di Carli MF; Dorbala S
Radiology; 2023 Feb; 306(2):e221082. PubMed ID: 36537896
[TBL] [Abstract][Full Text] [Related]
7. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
8. Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.
Castaño A; Bokhari S; Brannagan TH; Wynn J; Maurer MS
Amyloid; 2012 Mar; 19(1):41-6. PubMed ID: 22149423
[TBL] [Abstract][Full Text] [Related]
9. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative
Yabut J; Nadig V; Arora S; Hirsch D; Duvall WL
Circ Cardiovasc Imaging; 2024 Jan; 17(1):e015734. PubMed ID: 38146653
[No Abstract] [Full Text] [Related]
10.
Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
[TBL] [Abstract][Full Text] [Related]
11. Nuclear tracers for transthyretin cardiac amyloidosis: time to bone up?
Ruberg FL; Miller EJ
Circ Cardiovasc Imaging; 2013 Mar; 6(2):162-4. PubMed ID: 23512778
[No Abstract] [Full Text] [Related]
12. Standardization of
Bokhari S; Morgenstern R; Weinberg R; Kinkhabwala M; Panagiotou D; Castano A; DeLuca A; Kontak A; Jin Z; Maurer MS
J Nucl Cardiol; 2018 Feb; 25(1):181-190. PubMed ID: 27580616
[TBL] [Abstract][Full Text] [Related]
13. Bilateral Multiple Fractures Obstruct Quantitation of 99m Tc-Pyrophosphate Imaging for Cardiac Amyloidosis.
Zhou Q; Zuo J; Xiao L; Jiang L; Zhao Z
Clin Nucl Med; 2024 Jul; 49(7):e362-e363. PubMed ID: 38651782
[TBL] [Abstract][Full Text] [Related]
14. Imagine, believe, and achieve.
Peix A; Padrón K
J Nucl Cardiol; 2021 Jun; 28(3):831-834. PubMed ID: 33963494
[No Abstract] [Full Text] [Related]
15. Validation of the Kumamoto criteria for prediction of
Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis.
Miller RJH; Cadet S; Mah D; Pournazari P; Chan D; Fine NM; Berman DS; Slomka PJ
J Nucl Cardiol; 2021 Oct; 28(5):1835-1845. PubMed ID: 33689152
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.
Tamarappoo B; Otaki Y; Manabe O; Hyun M; Cantu S; Arnson Y; Gransar H; Hayes SW; Friedman JD; Thomson L; Slomka P; Dey D; Vescio R; Patel J; Berman DS
J Nucl Cardiol; 2020 Feb; 27(1):28-37. PubMed ID: 31172386
[TBL] [Abstract][Full Text] [Related]
18. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
[TBL] [Abstract][Full Text] [Related]
19. The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis.
Morfino P; Aimo A; Giorgetti A; Genovesi D; Merlo M; Limongelli G; Castiglione V; Vergaro G; Emdin M
Heart Fail Clin; 2024 Jul; 20(3):307-316. PubMed ID: 38844301
[TBL] [Abstract][Full Text] [Related]
20. A case of disappearing amyloid on technetium pyrophosphate scan.
Wang A; Mahmood U; Tang X; Jain D; Pan S
J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
